| abstract |
The present invention relates to certain hydroisoindoline compounds of formula I useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinins and especially substance P. The invention also relates to pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and formulations thereof in the treatment of certain conditions including emesis, urinary incontinence, depression, and anxiety. |